Event Title Go back to Home Page
Event Summary  
Event Type Medicine - Pharmaceutical Recalls  Date Time 2019-03-12 02:49:00 
Country US  City Silver Spring, MD 
Latitude 38.991  Longitude -77.026 
URL https://www.empr.com/home/news/generics-news/fda-approves-new-valsartan-product-following-major-recall/     
[empr.com] MARYLAND - FDA Approves New Valsartan Product Following Major Recall

"The Food and Drug Administration (FDA) has approved a new generic version of Diovan (Novartis) that does not contain N-nitrosodimethylamine (NDMA) or N-nitrosodiethylamine (NDEA), 2 potentially carcinogenic impurities identified in several recalled valsartan products."

Read the full article:



Copyright © 2006-2012  All Rights Reserved.